Turkalj S., Radtke F.A., Vyas P. 2023. An overview of targeted therapies in acute myeloid leukemia. Hemasphere. 7, E914. https://doi.org/10.1097/HS9.0000000000000914

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortes J. 2024. Quizartinib: A potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD–positive AML. J. Hematol. Oncol. 17, 111. https://doi.org/10.1186/s13045-024-01617-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montesinos P., Cheong J.W., Daver N., Fathi A.T., Levis M.J., Luger S., Miyamoto T., Oliva E.N., Perl A.E., Récher C., Schlenk R.F., Wang J., Zeidan A.M., Liu L., Duong Y., Imadalou K., Alexis K., Nahar A., Burns K., Erba H.P. 2024. Trial in progress: The phase 3, randomized, double-blind, placebo-controlled QuANTUM-Wild study of Quizartinib in combination with chemotherapy and as single-agent maintenance in newly diagnosed, FLT3-ITD-negative acute myeloid leukemia. Blood. 144 (Suppl. 1), 1504. https://doi.org/10.1182/blood-2024-205101

Article  Google Scholar 

Nepomuceno R., Rooks A.M., Gardner M., Armstrong R. 2014. Differential inhibition of FLT3-ITD, FLT3-WT, and KIT by Quizartinib as assessed by modified PIA Assay. Blood. 124 (21), 951. https://doi.org/10.1182/blood.V124.21.951.951

Article  Google Scholar 

Carranza-Aranda A.S., Jave-Suárez L.F., Flores-Hernández F.Y., Huizar-López M.D.R., Herrera-Rodríguez S.E., Santerre A. 2024. In silico and in vitro study of FLT3 inhibitors and their application in acute myeloid leukemia. Mol. Med. Rep. 30 (6), 229. https://doi.org/10.3892/mmr.2024.13353

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomovskaya Y.V., Kobyakova M.I., Senotov A.S. Lomovsky A.I., Minaychev V.V., Fadeeva I.S., Shtatnova D.Y., Krasnov, K.S., Zvyagina A.I., Akatov V.S., Fadeev R.S. 2022. Macrophage-like THP-1 cells derived from high-density cell culture are resistant to TRAIL-induced cell death via down-regulation of death-receptors DR4 and DR5. Biomolecules. 12, 150. https://doi.org/10.3390/biom12020150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lomovskaya Ya.V., Kobyakova M.I., Senotov A.S., Fadeeva I.S., Lomovsky A.I., Krasnov K.S., Shtatnova D.Yu., Akatov V.S. and Fadeev R.S. 2023. Myeloid differentiation increases resistance of leukemic cells to TRAIL-induced death by reducing the expression of DR4 and DR5 receptors. Biochem. (Moscow), Suppl. Ser. A, Membr. Cell Biol. 17 (1), 43–57. https://doi.org/10.1134/S1990747822060101

Article  CAS  Google Scholar 

Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102 (43), 15 545–15 550. https://doi.org/10.1073/pnas.0506580102

Article  CAS  Google Scholar 

Fang Z., Liu X, Peltz G. 2023. GSEApy: A comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics. 39 (1), btac757. https://doi.org/10.1093/bioinformatics/btac757

Chin C.H., Chen S.H., Wu H.H., Ho C.W., Ko M.T., Lin C.Y. 2014. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 (4), S11. https://doi.org/10.1186/1752-0509-8-S4-S11

Article  PubMed  PubMed Central  Google Scholar 

Bindea G., Mlecnik B., Hackl H., Charoentong P., Tosolini M., Kirilovsky A., Fridman W.H., Pagès F., Trajanoski Z., Galon J. 2009. ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 25 (8), 1091–1093. https://doi.org/10.1093/bioinformatics/btp101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benjamini Y., Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple Testing. J. R. Statist. Soc. Series B. 57, 289–300.

Article  Google Scholar 

Omage S., Wallert M., Lorkowski S. 2024. Cell culture of THP-1 monocytes and differentiation into macrophages with PMA v1. Protocols.io. 98576.https://doi.org/10.17504/protocols.io.5jyl8255dl2w/v1

Lomovskaya Y.V., Krasnov K.S., Kobyakova M.I., Kolotova A.A., Ermakov A.M., Senotov A.S., Fadeeva I.S., Fetisova E.I., Lomovsky A.I., Zvyagina A.I., Akatov V.S., Fadeev R.S. 2024. Studying signaling pathway activation in TRAIL-resistant macrophage-like acute myeloid leukemia cells. Acta Naturae. 16 (1), 48–58. https://doi.org/10.32607/actanaturae.27317

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsapogas P., Mooney C.J., Brown G., Rolink A. 2017. The cytokine Flt3-ligand in normal and malignant hematopoiesis. Int. J. Mol. Sci. 18 (6), 1115. https://doi.org/10.3390/ijms18061115

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kikushige Y., Yoshimoto G., Miyamoto T., Iino T., Mori Y., Iwasaki H., Niiro H., Takenaka K., Nagafuji K., Harada M., Ishikawa F., Akashi K. 2008. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J. Immunol. 180 (11), 7358–7367. https://doi.org/10.4049/jimmunol.180.11.7358

Article  CAS  PubMed  Google Scholar 

Ruglioni M., Crucitta S., Luculli G.I., Tancredi G., Del Giudice M.L., Mechelli S., Galimberti S., Danesi R., Del Re M. 2024. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy. Crit. Rev. Oncol. Hematol. 201, 104424. https://doi.org/10.1016/j.critrevonc.2024.104424

Article  PubMed  Google Scholar 

Reiterer G., Yen A. 2007. Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer. Res. 67 (16), 7765–7772. https://doi.org/10.1158/0008-5472.CAN-07-0014

Article  CAS  PubMed  Google Scholar 

Dong M., Blobe G.C. 2006. Role of transforming growth factor-beta in hematologic malignancies. Blood. 107 (12), 4589–4596. https://doi.org/10.1182/blood-2005-10-4169

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu T., Qi X., Cen J., Chen Z. 2012. Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro. Oncol. Rep. 28 (2), 622–628. https://doi.org/10.3892/or.2012.1825

Article  CAS  PubMed  Google Scholar